Cita APA

Granell Geli, J., Izquierdo, C., Sellés Rius, A., Teniente Serra, A., Presas Rodríguez, S., Mansilla, M. J., . . . Ramo Tello, C. (2021). Assessing Blood-Based Biomarkers to Define a TherapeuticWindow for Natalizumab.

Citación estilo Chicago

Granell Geli, Júlia, et al. Assessing Blood-Based Biomarkers to Define a TherapeuticWindow for Natalizumab. 2021.

Cita MLA

Granell Geli, Júlia, et al. Assessing Blood-Based Biomarkers to Define a TherapeuticWindow for Natalizumab. 2021.